|Articles|February 15, 2002

BioPharm International

  • BioPharm International-02-01-2002
  • Volume 15
  • Issue 2

Using a Model and Tools to Standardize the Preparation for a Preapproval Inspection

Author(s)Barbara Unger

By Barara W. Unger, Don Hill Associates, Inc., pp. 14-18, 71. An effective, well-developed, and versatile preapproval inspection model focuses management and inspectors on conclusions, minimizes process reinvention, and tracks inspection readiness, especially when you are using a contract manufacturer.
To view a PDF of this article from the BioPharm International archives, click this link

Articles in this issue

almost 24 years ago

Sale of Your Product Can Prevent Patenting: How to Avoid the On-Sale Bar

almost 24 years ago

Outsourcing Outlook: Reaping the Benefits of E-Procurement

almost 24 years ago

The Immunogenicity of Therapeutic Proteins

almost 24 years ago

Analytical Advances: Calibration Management of Outsourced Calibrations

almost 24 years ago

High-Throughput Biopharmaceutical Drug Development: Meeting the Coming Challenge

almost 24 years ago

Inside Washington: Costs and Controls Challenge Manufacturers

almost 24 years ago

21 CFR Part 11: (Un)Expected Added Value

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!